A&bgr; Monomers, Oligomers and Fibrils: Structural Features

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|7|3|198-213

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.7, Iss.3, 2011-09, pp. : 198-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Development of Preventives and Therapeutics for Alzheimer's Disease that Inhibit the Formation of &bgr;-Amyloid Fibrils (fA&bgr;), as Well as Destabilize Preformed fA&bgr;

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4357-4375

Bentham Science Publishers

Access to resources Recommend Favorite

Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

Reduction of A&bgr; Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for A&bgr; Production Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 671-676

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Modulation of A&bgr;42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4337-4355

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite